Artwork

Content provided by podcast@nature.com and Springer Nature Limited. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by podcast@nature.com and Springer Nature Limited or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Coronapod: new hope from COVID antiviral drugs

18:08
 
Share
 

Manage episode 307000843 series 3137
Content provided by podcast@nature.com and Springer Nature Limited. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by podcast@nature.com and Springer Nature Limited or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Two new anti-viral pills have been shown to be safe and effective against COVID in clinical trials, according to recent press releases. The drugs, molnupiravir, developed by Merck and Ridgeback Biotherapeutics, and Paxlovid, developed by Pfizer both appear to significantly reduce hospitalisation in people with early COVID. Some researchers are quietly hopeful that these new weapons in the anti-COVID arsenal could have a big impact, in particular in parts of the world where vaccines are still not widely available, but there are a number of caveats. In this episode of Coronapod, we open the pill boxes and pick through the contents - asking how the drugs work, what side effects we might see and how, if at all, they might change the course of the pandemic.


News: COVID antiviral pills: what scientists still want to know


Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

823 episodes

Artwork

Coronapod: new hope from COVID antiviral drugs

Nature Podcast

150,885 subscribers

published

iconShare
 
Manage episode 307000843 series 3137
Content provided by podcast@nature.com and Springer Nature Limited. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by podcast@nature.com and Springer Nature Limited or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Two new anti-viral pills have been shown to be safe and effective against COVID in clinical trials, according to recent press releases. The drugs, molnupiravir, developed by Merck and Ridgeback Biotherapeutics, and Paxlovid, developed by Pfizer both appear to significantly reduce hospitalisation in people with early COVID. Some researchers are quietly hopeful that these new weapons in the anti-COVID arsenal could have a big impact, in particular in parts of the world where vaccines are still not widely available, but there are a number of caveats. In this episode of Coronapod, we open the pill boxes and pick through the contents - asking how the drugs work, what side effects we might see and how, if at all, they might change the course of the pandemic.


News: COVID antiviral pills: what scientists still want to know


Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

823 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide